Abstract:Through the combined use of (18)F-fallypride positron emission tomography and magnetic resonance imaging this study examined the neural mechanisms underlying the attentional deficits associated with attention deficit/hyperactivity disorder and their potential reversal with a single therapeutic dose of methylphenidate. Sixteen adult patients with attention deficit/hyperactivity disorder and 16 matched healthy control subjects were positron emission tomography and magnetic resonance imaging scanned and tested on a computerized sustained attention task after oral methylphenidate (0.5 mg/kg) and placebo administration in a within-subject, double-blind, cross-over design. Although patients with attention deficit/hyperactivity disorder as a group showed significant attentional deficits and reduced grey matter volume in fronto-striato-cerebellar and limbic networks, they had equivalent D2/D3 receptor availability and equivalent increases in endogenous dopamine after methylphenidate treatment to that observed in healthy control subjects. However, poor attentional performers drawn from both the attention deficit/hyperactivity disorder and the control groups had significantly reduced left caudate dopamine activity. Methylphenidate significantly increased dopamine levels in all nigro-striatal regions, thereby normalizing dopamine levels in the left caudate in low performers. Behaviourally, methylphenidate improved sustained attention in a baseline performance-dependent manner, irrespective of diagnosis. This finding was accompanied by an equally performance-dependent effect of the drug on dopamine release in the midbrain, whereby low performers showed reduced dopamine release in this region. Collectively, these findings support a dimensional model of attentional deficits and underlying nigro-striatal dopaminergic mechanisms of attention deficit/hyperactivity disorder that extends into the healthy population. Moreover, they confer midbrain dopamine autoreceptors a hitherto neglected role in the therapeutic effects of oral methylphenidate in attention deficit/hyperactivity disorder. The absence of significant case-control differences in D2/D3 receptor availability (despite the observed relationships between dopamine activity and attention) suggests that dopamine dysregulation per se is unlikely to be the primary cause underlying attention deficit/hyperactivity disorder pathology in adults. This conclusion is reinforced by evidence of neuroanatomical changes in the same set of patients with attention deficit/hyperactivity disorder.

Stimulants improve theory of mind in children with attention deficit/hyperactivity disorder

Theory of Mind and Empathy in Children With ADHD

Effects of Extended-released Methylphenidate on the Inhibition of Children with Attention Deficit Hyperactivity Disorder

Effect of short-term methylphenidate on social impairment in children with attention deficit/hyperactivity disorder: systematic review

Functional Near-Infrared Spectroscopy Study on Inhibitory Control Ability of Children with Attention Deficit Hyperactivity Disorder with Methylphenidate Therapy: an Experimental, Longitudinal, and Neuroimaging Study

Neural Correlates of Theory of Mind in Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and the Comorbid Condition

Executive Function and Theory of Mind in Children with ADHD: a Systematic Review

Improvements of attention deficit/hyperactivity disorder core symptoms and executive function after methylphenidate treatment

The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder

Functional Mri in Attention-Deficit Hyperactivity Disorder: Evidence for Hypofrontality

Effect of methylphenidate on functional controllability: a preliminary study in medication-naïve children with ADHD

A Positron Emission Tomography Study of Nigro-Striatal Dopaminergic Mechanisms Underlying Attention: Implications for ADHD and Its Treatment.

Verbal Working Memory-Related Functional Connectivity Alterations in Boys with Attention-Deficit/hyperactivity Disorder and the Effects of Methylphenidate.

A preliminary study of the effects of stimulant medications on estimates of psycholinguistic abilities for children with attention-deficit/hyperactivity disorder

Stimulant medication and symptom interrelations in children, adolescents and adults with attention-deficit/hyperactivity disorder

Social Cognition in Children with High-Functioning Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Associations with Executive Functions

Technetium 99m Ethylcysteinate Dimer Single-Photon Emission Computed Tomography (SPECT) During Intellectual Stress Test in Children and Adolescents With Pure Versus Comorbid Attention-Deficit Hyperactivity Disorder (ADHD)

The Effects of Psychostimulants on Cognitive Functions in Individuals with Attention-Deficit Hyperactivity Disorder: A Systematic Review

Hot executive control and response to a stimulant in a double-blind randomized trial in children with ADHD

Neural Correlates of Symptom Improvement Following Stimulant Treatment in Adults with Attention-Deficit/Hyperactivity Disorder

Methylphenidate is more effective to improve inhibitory control and working memory compared to tDCS in children and adolescents with attention deficit/hyperactivity disorder: a proof-of-concept study